In addition to opening a new window into how human genetic mutations can operate, the researchers hope that their insights lead to new strategies that improve or ultimately save the lives of people ...
SAN FRANCISCO – Speaking Monday at the JP Morgan Healthcare Conference, Tempus AI CEO and Founder Eric Lefkofsky provided more detail about the company's $600 million acquisition of Ambry Genetics, ...
Together, these studies represent a major step forward in variant classification, providing essential data that helps clinicians better assess cancer risks tied to genetic mutations. Ambry ...
The University of Texas MD Anderson Cancer Center and Myriad Genetics (MYGN) announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad’s molecular ...
We are working with Guy’s and St. Thomas’ NHS Foundation Trust to produce national standardised SACT regimen-specific consent forms. We want to support clinicians in ensuring all patients are fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results